NIA Renewal and Revision Cooperative Agreements in AD/ADRD Research (U24 Clinical Trial Not Allowed)

The National Institute on Aging (NIA) has announced a funding opportunity for the renewal, competitive revision, and resubmission applications of previously funded U24 Research Resource/Infrastructure applications. This opportunity, titled "NIA Renewal and Revision Cooperative Agreements in AD/ADRD Research" is specifically focused on large-scale, complex research programs that aim to investigate Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRD).

The NIA anticipates that a single institution or a consortium of institutions will use these programs for their research. Moreover, the research should align with one or more AD/ADRD implementation research milestones. This is crucial as it helps in supporting the wider research objectives outlined in the National Plan to Address Alzheimer's and Related Dementias. It's worth noting that this funding opportunity is not permitted for clinical trials.